Home/Filings/4/A/0001437749-18-000886
4/A//SEC Filing

Ma Yonghao 4/A

Accession 0001437749-18-000886

CIK 0001389545other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 5:29 PM ET

Size

5.5 KB

Accession

0001437749-18-000886

Insider Transaction Report

Form 4/AAmended
Period: 2017-01-03
Ma Yonghao
Director
Transactions
  • Award

    stock option (right to buy)

    2017-01-03+20,32623,629 total
    Exercise: $3.24From: 2017-01-03Exp: 2027-01-03Common Stock (20,326 underlying)
Footnotes (4)
  • [F1]Stock options will vest in equal monthly installments starting on the date of grant.
  • [F2]Granted pursuant to the 2007 Omnibus Incentive Plan and the 2017 Non-Employee Director Compensation Plan.
  • [F3]Amended Form 4 filed to fix the share amount on previous filing. Grant should be in the amount of 20,326, not 33,699.
  • [F4]Amended Form 4 to state that total stock options held is 23,629, not 37,002 as previously reported.

Documents

1 file

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeother

Related Parties

1
  • filerCIK 0001683136

Filing Metadata

Form type
4/A
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:29 PM ET
Size
5.5 KB